The hist quarter of the century has seen biological psychiatry growing from its itifancv to a lolesr. Mice. A mo tg the many theories propounded about the ncurobiolog'cal mechanisms in major functional psvehoses, Dexatnuthasone Suppression Test (DST) has emerged to be the most promising otic. The piotver in t It is field was B. J. Carroll (1982) who along with M. Keiuberg, M. Steiner and co-workers had do lie illicit to stiidardise the test for use in psychiatry.
DST lias been called a> laboratory marker of eulogenous depressed state (Carroll et al. . H)80\ Respon.se to DST is non suppressive during melancholia and suppressive during eutlivmia (Carroll, 1972) .
Newer studies have suggested that DST m : ght serve as an anci Diary index to predict clinical response and outcome of depression (Carroll et al., 1968) . The DST tends to normalize as depression subsides (Carroll, 1982 ; Ore den et al.. 1980 ) and may even normalize well before clinical improvement which may have a predictive value for good treatment response. Coryell (1982) has predicted good ECT response when an abnormal DST was found at discharge. However, it was also .suggested that ECT may be affecting hypothalamic structures which invalidate its use as response predictor (Grunhamsct al.. 1983 ).
The PDPC levels have been used in monitoring of antidepressant treatment (Grcden et al., 1983 utilisation of a uniform procedure for the measurement of PDPC and its use in depressives treated with ECT and antidepressant drugs, we had planned a prospective study with the following aims : 1. To assess the relationship of post dexamethasone plasma Cortisol levels and severity of depression in endogenous depressives.
2. To study the effect of treatment (ECT and Imipramine) and clinical response on PDPC.
Material and Methods
The study was performed on an open parallel des'gn. The patients were randomly assigned for treatment to either drugs or ECT. The patients of the experimental group comprised of 60 patients (drawn from the inpatient, Department of Psychiatry, K. G's. Medical College, Lucknow) diagnosed as Manic Depressive Psychosis Depression (ICD-9, VVHOj and fulfilling the Research Diagnostic Criteria for major depression (Spitzer et al., 1978) . The patients were between the age of 17-55 years and were evaluated on a preset selection criteria. The control group consisted of 30 normal subjects having no medical or psychiatric illness and matched for age and sex with the experimental group. They were evaluated clinically as well as on Cornell Medical Index (Broadman et al., 1949) to rule out psychiatric illness. The control group was taken to compare its values with that of depress ives The patients were evaluated on screening schedule, semistructured proforma, Research Diagnostic Criteria and Hamilton Rating Scale for depression (HRSD) (Hamilton. I960] at the commencement of the study. An informed consent was also obtained from each patient and control. These patients were kept under observation for 7 clays (as a washout period of any drug taken,) and those patients whose HRS-D score was 17 or more on 7th day (day 0) were only included in the study.
The patients of ECT group were given biweekly direct ECT's (direct ECT's were given to exlude the effect of drugs used in anaesthesia) upto a maximum of 10 treatments. However, the treatment was stopped when HRS-D levels fell to 5 or less. No extra medication was given apart from nitrazepam on SOS basis. The patients of the antidepressant group received a fixed dose of Imipramine, 75 mg/day initially which was increased to 225 mg/day within a week. The drug was stopped when HRS-D fell to 5 or less.
Weekly estimations of HRS-D and PDPC was done in both the groups. PDPC estimations was done by giving I mg of dexamethasone to the patient at II P. M. followed by sampling of blood at 4 P.M. on the following day. The plasma was separated and PDPC levels estimated by sepcu'otluorometric method (Mattingly, 1962) . PDPC and HRS-D was estimated on Day 0 and there after every week on day 7, 14, 21, 28 and 35 or stopped earlier when HRS-D score fell to 5 or less . Only one point PDPC was done on the control group.
Results
Sixty depressed and thirty controls were compared for PDPC values. The mean PDPC values of the depressed patients ('pre treatment) was 18.2±6.2 /ig/dl (range 10.5-39.6; as compared to 11.9 -i-4.2 /ig/dl (range 7.2-19.5) that of controls. There was a significantly higher PDPC values in depressed patients as cornpared to the controls. Thirty seven out of sixty patients had their first episode of depression while the rest had two or more episodes.
When mean PDPC was compared in the male and female deprcssives it was found to be statistically non significant. The mean PDPC levels of the depressed .') (rang-: l ( )-36i. There was s'g ufie.iul correlation found between PDPC levels and severity of illness, i.e. the PDPC tends to increase with increasing severity of illness (r: 0.71; p>0.001).
The uv an PDPC levels in the, patie'Us treate.d with F,CT and those treated with luiipraiuiue. were fonnd to change significantly <>u clinical improvement in their depressive status. Thus pre and posl treatment PDPC values in the l',CT in:.tied group was 20.7 /^g/dl and IS.tifig'dl ivsp.-etivrly. There was a siguilieaut decrease in the mean PDPC from 17.'i jig.'dl t >> 12.7 jig'dl in the Imipramini: group (Table . \o significant difference was found iu the l'DPC values of MDP-depiessed type and MDP eirculai eui'i'etltly de- on FX1T showed quick recovery (50% improved within three weeks) as compared to patients on Imipramine (37% improved within three weeks). This shows that patients on ECT tend to respond faster than on pharmacotherapy. Another finding was the significant decrease of plasma Cortisol levels in the improved group.
Discussion
The DST has been primarily investigated as an aid in diagnosing endogenous depression, yet its major clinical use has been as a predictor of treatment response. It is commonly held that as abnormal DST predicts response to somatic therapies. Gitlin and Garner (1986) reviewed 16 published reports and found that DST predicted response to somatic therapies in only 6 of them.
No difference could be detected in overall therapeutic improvement between those patients with a normal or abnormal DST respectively based on 5 ug'dl Cortisol cut off point used by Coppen et id. (1985) .
However, when they increased the cut off point to 10 jLtg/dl it was found that patients having PDPC more than 10 /tg/dl rsesponded significantly better than those who had a normal DST response. This was found to be independent of the treatment modality used. Our findings are in agreement with the above study. The patients of the improved group had a higher mean PDPC as compared to the patients of the non improved group (The patients of the improved group had mean PDPC of 20. 7 and 17.9 M g/dl in the EGT and Imipramine group respectively whereas the non improved had 13.1 and 13.7 /xg/dl in thees two groups.
The PDPC levels in the present sample was found to be significantly higher in depressed patients as compared to normal controls (p<0.001). This is in agreement with McGlure (1966), Carpenter and Bunney (1971), Carroll (1978) , Verghese et al. (1973) . However, Shopsin and Gershon (1971) could not find any difference in PDPC levelsin the depressives and controls.
Several studies (McGlure, 1966 ; Goppen, 1967 and Sethi and Sethi, 1971) have reported that higher plasma Cortisol levels were found during hightened state depression thus indicating the increased of secretion of plasma Cortisol in severe depressives. Similar findings were observed in the present study when a significant correlation was found between PDPC levels and severity of depression . However, this is not universally accepted and some authors Davies, 1970 and Verghese et al., 1973) had presented contradictory reports.
Patients of the EGT treated group as well as, imipramine treated group showed significant improvement (Table) and a singificant decrease in PDPC values. This goes on to prove that PDPC is independent of the treatment modality used.
As Galen and Gambino (1975) stated, "the monitoring of treatment is one of the most persuasive reasons for ordering a laboratory test", DST is all set to fulfil the above requirement in the years to come.
